ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,213,000 | +40.6% | 30,000 | +100.0% | 0.05% | +58.8% |
| Q2 2015 | $863,000 | +171.4% | 15,000 | +200.0% | 0.03% | +142.9% |
| Q1 2015 | $318,000 | +2.9% | 5,000 | 0.0% | 0.01% | +27.3% |
| Q4 2014 | $309,000 | -20.4% | 5,000 | -50.0% | 0.01% | +22.2% |
| Q3 2014 | $388,000 | -40.1% | 10,000 | -46.8% | 0.01% | -35.7% |
| Q2 2014 | $648,000 | +70.5% | 18,800 | +113.6% | 0.01% | +75.0% |
| Q1 2014 | $380,000 | -52.8% | 8,800 | -56.5% | 0.01% | -55.6% |
| Q4 2013 | $805,000 | +7.3% | 20,210 | +1.0% | 0.02% | +125.0% |
| Q3 2013 | $750,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |